Stock Sale, Buyback News

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as material inducements to four individuals whose employment commenced in either November 2025 or December 2025. The grants, in the form of Restricted Stock Units (RSUs), totaled...

PARIS LA DÉFENSE--(BUSINESS WIRE)--Regulatory News: Under the liquidity contract implemented by Arkema (Paris:AKE) with NATIXIS ODDO BHF, as of 31 December 2025, the following assets were held in the dedicated liquidity account: 141,945 shares €5,727,787 For the period from 01 July 2025 to 31 December 2025, the following transactions have been carried out: Number of executed transactions on buy side: 13,401 Number of executed transactions on sell side: 12,605 Traded volume on buy side: 1,568,34...

MINNEAPOLIS--(BUSINESS WIRE)--X3 Acquisition Corp. Ltd. (NASDAQ: XCBEU) (the “Company”) today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The Company’s units will be listed on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “XCBEU” and will begin trading on January 21, 2026. Each unit to be issued in the offering consists of one Class A ordinary share of the Company and one-half of one redeemable warrant, with each whole wa...

GENEVA--(BUSINESS WIRE)--Alcon Completes $750 Million Share Repurchase Program...

GENEVA--(BUSINESS WIRE)--Alcon Completes $750 Million Share Repurchase Program...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/01/2026 FR0014000MR3 10 000 70.5975 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/01/2026 FR0014000MR3 5 000 72.9633 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 14/01...

DALLAS--(BUSINESS WIRE)--LibertyStream Infrastructure Partners Inc. (TSXV: LIB | OTCQB: VLTLF | FSE: I2D) (“LibertyStream” or the “Company”) is pleased to announce that, in response to strong investor demand, it has upsized the non-brokered private placement offering (the “Offering”) of units of the Company (the “Units”) at a price of $1.10 per Unit originally announced on January 16, 2026. The Offering has been increased by $2,500,000, raising the maximum aggregate proceeds from $10,000,000 to...

PARIS--(BUSINESS WIRE)--Havas reports the progress of transactions under its current share buyback program...

DALLAS--(BUSINESS WIRE)--LibertyStream Infrastructure Partners Inc. (TSXV: LIB | OTCQB: VLTLF | FSE: I2D) (“LibertyStream” or the “Company”) is pleased to announce a non-brokered private placement offering (the “Offering”) of units of the Company (the “Units”) at a price of $1.10 per Unit for aggregate proceeds of up to $10,000,000. Each Unit will be comprised of one common share of the Company (each, a “Common Share”) and one whole common share purchase warrant (each, a “Warrant”). Each Warran...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that on January 15, 2026, it granted options to purchase an aggregate of 50,000 shares of DiaMedica’s common stock to a newly hired non-executive employee whose employment commenced in December 2025. The stock options were a material inducement to the emplo...